VisionGate, a Breakthrough Liquid-biopsy Technology Company, Leads the Battle Against Lung Cancer through Early Detection Technology with a Simple, Non-Intrusive Sputum Test.

VisionGate wants you to live your life with peace of mind. That’s why we’ve launched a new website that makes it easy for you to learn more about our advanced lung cancer detection technology. Our new site also features resources to help you better understand the different types of lung cancer and common risk factors.

Our mission is to save lives through early detection and prevention of lung cancer with a simple, non-intrusive test. Harnessing the power of cutting-edge technology, the future is now – thanks to our 3D cell imaging and AI-powered cancer detection process.

We’re backed by a talented team of scientists, researchers and doctors spanning over 150 years of combined experience in the field of pharmaceuticals and diagnostics. Our team is bringing the world ground-breaking early-stage lung cancer detection methods to help you live your best life.

Learn more about the life-saving mission and experienced team.